I agree that this site is using cookies. You can find further informations here.
X
Brandi, Henrik
45  results:
Search for persons X
?
1

Incremental Risk of Adverse Events with Oral Janus Kinase I..:

Brandi, Henrik ; Schneider, Shannon ; Ryttig, Lasse
SKIN The Journal of Cutaneous Medicine.  8 (2024)  1 - p. s320 , 2024
Link: https://doi.org/10.25251..
 
?
2

Patient Preferences in the Treatment of Moderate-to-severe ..:

Ameen, Mahreen ; Alhusayen, Raed ; Brandi, Henrik...
Acta Dermato-Venereologica.  104 (2024)  - p. adv24339 , 2024
Link: https://doi.org/10.2340/..
 
?
3

A Cost-Utility Analysis of SQ® Tree SLIT-Tablet versus Plac..:

Pollock, Richard F ; Slættanes, Andreas K ; Brandi, Henrik.
ClinicoEconomics and Outcomes Research.  15 (2023)  - p. 69-86 , 2023
Link: https://doi.org/10.2147/..
 
?
4

Preference for sublingual immunotherapy with tablets in a S..:

Bøgelund, Mette ; Ingelmo, Ana Rosado ; Ruiz, Jose María Ausín...
Clinical and Translational Allergy.  12 (2022)  2 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
5

Matching-adjusted indirect comparison of efficacy outcomes ..:

Papp, Kim A. ; Thoning, Henrik ; Gerdes, Sascha...
Journal of Dermatological Treatment.  33 (2022)  7 - p. 3005-3013 , 2022
Link: https://doi.org/10.1080/..
 
?
6

ITULAZAX® versus Alutard SQ® in the treatment of allergic r..:

Rønborg, Steen M. ; Grand, Tobias Sydendal ; Brandi, Henrik.
Clinical and Translational Allergy.  12 (2022)  11 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
7

Preference for Immunotherapy with Tablets by People with Al..:

Tankersley, Mike ; Winders, Tonya ; Aagren, Mark...
Patient Preference and Adherence.  15 (2021)  - p. 2539-2549 , 2021
Link: https://doi.org/10.2147/..
 
?
8

Subcutaneous immunotherapy takes more than the time in the ..:

Tankersley, Mike ; Winders, Tonya ; Aagren, Mark...
Current Medical Research and Opinion.  37 (2021)  11 - p. 1925-1931 , 2021
Link: https://doi.org/10.1080/..
 
?
9

Application of a Mapping Function to Estimate Utilities for..:

Dick, Katherine ; Briggs, Andrew ; Brandi, Henrik
PharmacoEconomics - Open.  4 (2020)  4 - p. 649-655 , 2020
Link: https://doi.org/10.1007/..
 
?
10

A Cost-Utility Analysis of SQ® Tree SLIT-Tablet versus Plac..:

Pollock, Richard F ; Slættanes, Andreas K ; Brandi, Henrik.
info:eu-repo/semantics/altIdentifier/doi/10.2147/CEOR.S377399.  , 2023
Link: https://www.dovepress.co..
 
?
11

A Cost-Utility Analysis of SQ(®) Tree SLIT-Tablet versus Pl..:

Pollock, Richard F ; Slættanes, Andreas K ; Brandi, Henrik.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904213/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
12

Matching-adjusted indirect comparison of efficacy outcomes ..:

Papp, Kim A ; Thoning, Henrik ; Gerdes, Sascha...
Journal of Dermatological Treatment.  , 2022
Link: https://ddd.uab.cat/reco..
 
?
13

Preference for sublingual immunotherapy with tablets in a S..:

Bøgelund, Mette ; Ingelmo, Ana Rosado ; Ruiz, Jose María Ausín...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814907/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
14

ITULAZAX(®) versus Alutard SQ(®) in the treatment of allerg..:

Rønborg, Steen M ; Grand, Tobias Sydendal ; Brandi, Henrik.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631325/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

Preference for Immunotherapy with Tablets by People with Al..:

Tankersley, Mike ; Winders, Tonya ; Aagren, Mark...
info:eu-repo/semantics/altIdentifier/doi/10.2147/PPA.S338337.  , 2021
Link: https://www.dovepress.co..
 
1-15